You searched for "diabetic"
Randomisation, confounding & observational methods in ophthalmic epidemiology
1 June 2022
| Skanda Rajasundaram, Dalia Abdulhussein, Christopher Bentley (Prof), Minak Bhalla
|
EYE - General
Randomisation and confounding Understanding the relationship between an exposure and an outcome of interest is the central challenge in ophthalmic epidemiology. The exposure may be aetiological, taking the form of a putative risk biological factor, or therapeutic, in the form...
Cementing a VISION 2020 LINK partnership between Blantyre and Liverpool – building capacity for DR services alongside research
1 August 2016
| Petros Kayange, Gerald Msukwa, Michael Briggs, Marcia Zondervan, Nicholas Beare
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Malawi is a small land-locked country in eastern Africa with a growing population of over 17 million people. About 45% of the population is aged 14 or under; only 5% are aged 60 or over. The gross national income per...
The role of inflammation in the pathophysiology of DMO
1 February 2016
| Fiona Harris, Spyridon Chalkiadakis, Simon Taylor (Prof)
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...
Twenty-five years in retina
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...Sustainability in eyecare: Are virtual clinics the way forward in the diagnosis and monitoring of retinal disease?
Virtual clinics can be used successfully in screening and management of ocular conditions such as diabetic retinopathy, retinopathy of prematurity and age-related macular degeneration. Virtual clinics should be a considered as a more clinically appropriate modality of consultation, diagnosis and...Development of eyecare services in Dominica: Past, present, and future
3 October 2024
| Hazel Shillingford-Ricketts, Kevin Melanson, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
Dominica is a small island developing state in the Caribbean with a population of approximately 73,000 people [1] and has a long and proud history of developing eyecare services through international partnerships. This article will give you an outline of...
BARS (British Association of Retinal Screening) Conference 2023
28 September 2023
-29 September 2023
Why not join us at the BARS Conference 2023 in the vibrant city of Bristol, at the Marriott Hotel on Thursday 28 and Friday 29 September. This year there is something for everyone with an interest in diabetic eye screening....
The results of the last survey Jun25
The first question refers to whether we check blood glucose levels prior to cataract surgery. Almost three quarters of you do which was interesting. We know that poor glycaemic control (manifesting as a raised HbA1c) has implications for wound healing...Yorkshire Retina Society Winter Meeting 2024
3 December 2024
by Madiah Mahmood, Junior Medical Education Fellow, Bradford Teaching Hospitals and Foundation Trust, UK; Ewan McCallum, Consultant Ophthalmologist, Bradford Teaching Hospitals and Foundation Trust, UK. The Yorkshire Retina Society is one of the largest regional subspecialty societies in the UK,...
The risk factors associated with isolated microvascular third nerve palsy
3 April 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors used the Rochester Epidemiology Project for this retrospective case review of third nerve palsy. Inclusion criteria was adults >18 years, with new onset isolated microvascular third nerve palsy diagnosed within a 36-month period, with recovery or significant improvement,...
Innovation update: key advances in eyecare transformation in the last year
1 December 2021
| Vishal Shah, Alexander Chiu, Guy Mole, Melanie Hingorani
|
EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
Vishal Shah and his co-authors reflect on examples of innovation in eyecare delivery published in the last year and the implications for the future of eyecare services. The “new normal” is an overused phrase to describe extraordinary measures that have...
RaScaL Study
1 June 2015
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...